Skip to content
Monday, April 20, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Trump, on eve of new ceasefire talks: ‘Israel never talked me into the war with Iran’ April 20, 2026
  • Ye concerts scrapped in Poland, Switzerland as backlash over antisemitic remarks continues April 20, 2026
  • Police eye Iran involvement as 3 London synagogues are targeted in arson attacks April 20, 2026
  • Rabbis of LA | For Rabbi Guzik, Being a Rabbi and a Therapist ‘Are the Same Thing’ April 17, 2026
  • Meaningful Activism – Not Intimidation – Makes Change Possible April 17, 2026
  • Jewish groups urge Trump to prioritize Americans held in Iran during ceasefire talks April 17, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.